Northern Trust’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Northern Trust’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-63,167	Closed	-$35K	–	4283
2016 Q3	$35K	Sell	63,167 -3,222	-5%	-$1.47K	﹤0.01%	4058
2016 Q2	$39K	Sell	66,389 -438,592	-87%	-$468K	﹤0.01%	4051
2016 Q1	$738K	Buy	504,981 +981	+0.2%	+$1.94K	﹤0.01%	3351
2015 Q4	$1.61M	Sell	504,000 -9,152	-2%	-$44K	﹤0.01%	3156
2015 Q3	$3.21M	Buy	513,152 +38,857	+8%	+$363K	﹤0.01%	2750
2015 Q2	$4.71M	Buy	474,295 +72,387	+18%	+$634K	﹤0.01%	2560
2015 Q1	$2.96M	Buy	401,908 +16,756	+4%	+$113K	﹤0.01%	2856
2014 Q4	$2.06M	Buy	385,152 +5,161	+1%	+$26.4K	﹤0.01%	3084
2014 Q3	$1.91M	Buy	379,991 +286,441	+306%	+$1.76M	﹤0.01%	3132
2014 Q2	$628K	Buy	93,550 +39,763	+74%	+$253K	﹤0.01%	3538
2014 Q1	$390K	Sell	53,787 -731	-1%	-$4.33K	﹤0.01%	3607
2013 Q4	$205K	Buy	54,518 +33,441	+159%	+$129K	﹤0.01%	3711
2013 Q3	$70K	Buy	+21,077	New	+$73.4K	﹤0.01%	3887

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

MBT

Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Northern Trust's NWBO Position: Q4 2016 in Review

Northern Trust sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 63,167 shares — an estimated $35K sold.

Northern Trust first reported a position in NWBO in Q3 2013 and held it in 13 quarters. The position peaked at $4.71M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

Northern Trust reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
Northern Trust sold 63,167 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $35K.
Northern Trust first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2013 and held it in 13 quarters.
Northern Trust's Northwest Biotherapeutics, Inc. Common stock position peaked at $4.71M in Q2 2015.
8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.